BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM;PRESIDENT AND FELLOWS OF HARVARD COLLEGE
发明人:
Andrew Curtis KRUSE,Assaf ALON,Hayden R. SCHMIDT,Stephen MARTIN,James SAHN,Michael WOOD
申请号：
US16488010
公开号：
US20200000822A1
申请日:
2018.02.23
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure provides methods of treating cancer, sterol homeostasis diseases, and neurological diseases using compounds which modulate the activity of sigma receptors. In particular, the present disclosure provides method s of modulating the sigma 2 receptor for use in treating one or more diseases associated with that sigma receptor.
